The U.S. Supreme Court’s decision to review Purdue Pharma’s chapter 11 case poses a threat to the grants of legal immunity that keep businesses owners, executives and affiliates safe from lawsuits through a bankruptcy restructuring.
The justices on Thursday agreed to examine whether the closely held drugmaker can restructure in chapter 11 while shielding its wealthy owners from lawsuits over its past sales of OxyContin. The Justice Department has challenged Purdue’s deal with members of the Sackler family—and the popular legal…
#Supreme #Court #Review #Purdue #Settlement #Shake #Bankruptcy #System
